Open-label tofacitinib and double-blind atorvastatin in rheumatoid arthritis patients: a randomised study - McInnes, Iain B; Kim, Ho-Youn; Lee, Sang-Heon; Mandel, David; Song, Yeong-Wook; Connell, Carol A; Luo, Zhen; Brosnan, M Julia; Zuckerman, Andrea; Zwillich, Samuel H; Bradley, John D (Annals of the rheumatic diseases, 2014)
Keywords: Administration, Oral; Adult; Arthritis, Rheumatoid - complications; Arthritis, Rheumatoid - drug therapy; Atorvastatin; Cardiovascular Diseases - complications; Cardiovascular Diseases - drug therapy; Cholesterol; Cytokines; Disease; Double-Blind Method; Drug dosages; Drug Therapy, Combination; Family medical history; Female; Follow-Up Studies; Heptanoic Acids - administration & dosage; Heptanoic Acids - adverse effects; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage; Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects; Lipids; Lipids - blood; Low density lipoprotein; Male; Middle Aged; Mortality; Neutrophils; Piperidines - administration & dosage; Piperidines - adverse effects; Placebos; Protein Kinase Inhibitors - administration & dosage; Protein Kinase Inhibitors - adverse effects; Pyrimidines - administration & dosage; Pyrimidines - adverse effects; Pyrroles - administration & dosage; Pyrroles - adverse effects; Rheumatoid arthritis; Studies; Treatment Outcome; Rheumatoid Arthritis; Lipids; Treatment